Company Search:
Advanced Search
Sponsored Links
Bayer AG Company Snapshot
Bayer AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other pharmaceutical manufacturers in Europe: GlaxoSmithKline plc of the United Kingdom (2018 sales of £30.82 billion [US$40.08 billion] of which 56% was Pharmaceuticals), Sanofi S.A. of France (35.68 billion Euro [US$39.55 billion] of which 69% was Pharmaceuticals), and Novartis AG which is based in Switzerland (51.94 billion Swiss Francs [US$53.66 billion] of which 66% was Innovative Medicines).

Sales Analysis. Bayer AG reported sales of 39.59 billion Euro (US$43.89 billion) for the year ending December of 2018. This represents an increase of 13.1% versus 2017, when the company's sales were 35.02 billion Euro. Despite this increase, sales are still well below the level achieved in 2016, when Bayer AG reported sales of 46.77 billion Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Bayer AG had sales of 40.16 billion Euro. Sales of Cropscience saw an increase that was more than double the company's growth rate: sales were up 49.0% in 2018, from 9.58 billion Euro to 14.27 billion Euro. Bayer AG also saw significant increases in sales in All Other Segments (up 40.5% to 1.61 billion Euro) . Not all segments of Bayer AG experienced an increase in sales in 2018: sales of Consumer Care fell 7.0% to 5.45 billion Euro. Bayer AG also experienced decreases in sales in Pharmaceuticals and Biological Products (down 0.6% to 16.75 billion Euro) and Animal Health (down 4.5% to 1.50 billion Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Bayer AG
  Stock Performance Chart for Bayer AG
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 75.25
(Figures in Euro)
1 Week -0.1%   13 Weeks 5.2%  
4 Weeks 15.3%   52 Weeks 13.2%  
Bayer AG Key Data:
  Ticker: BAYN Country: Germany
  Exchanges: NYSE AMS BRU DUS FRA GVA LON PAR TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 39,586,000,000
(Year Ending Jan 2019).
Employees: 116,998
  Currency: Euro Market Cap: 70,174,535,291
  Fiscal Yr Ends: December Shares Outstanding: 932,551,964
  Share Type: Stammaktie Closely Held Shares: 3,903
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.